by DB Insurance | Feb 28, 2019 | Uncategorized
Bristol-Myers Squibb Co’s top shareholder Wellington Management said on Wednesday it does not support the U.S. drugmaker’s $74 billion deal to buy biotech Celgene Corp, imperiling what would be the largest pharmaceutical acquisition of all time.
by DB Insurance | Feb 27, 2019 | Uncategorized
An experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients, scientists said on Wednesday, although they cautioned that a clinical trial was not able to prove the treatment slowed or halted the neurodegenerative disease.
by DB Insurance | Feb 26, 2019 | Uncategorized
Brazil’s health agency has concluded a re-evaluation of the safety of the weedkiller glyphosate, the most widely-used agriculture chemical in the country, and will present the findings and recommended guidelines for its future use on Tuesday, an official...
by DB Insurance | Feb 25, 2019 | Uncategorized
A global coalition set up to fight emerging epidemics has struck a $31 million deal with scientists at Japan’s University of Tokyo to speed up work on a vaccine against a brain-damaging disease caused by the Nipah virus.
by DB Insurance | Feb 24, 2019 | Uncategorized
Authorities in the United States have charged a man accused of leaking information on thousands of HIV victims in Singapore with possession and unlawful transfer of stolen documents.
